Profile of baseline CD4 T-lymphocyte and viral load levels in HIV infected treatment naive patients in Lagos, Nigeria. 2006

Emmanuel O Idigbe, and Rosemary A Audu, and Olumuyiwa B Salu, and Joseph I Onyewuche, and Chinedum T Oparaugo, and Adesola Z Musa, and Emily H Meschack, and Ugochukwu F Sylvester-Ikondu
Human Virology Laboratory, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.

UI MeSH Term Description Entries
D009549 Nigeria A republic in western Africa, south of NIGER between BENIN and CAMEROON. Its capital is Abuja. Federal Republic of Nigeria
D003376 Counseling The giving of advice and assistance to individuals with educational or personal problems.
D006266 Health Education Education that increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of health on a personal or community basis. Community Health Education,Education, Health,Education, Community Health,Health Education, Community
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D019562 Viral Load The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression. Viral Burden,Virus Titer,Burden, Viral,Load, Viral,Titer, Virus

Related Publications

Emmanuel O Idigbe, and Rosemary A Audu, and Olumuyiwa B Salu, and Joseph I Onyewuche, and Chinedum T Oparaugo, and Adesola Z Musa, and Emily H Meschack, and Ugochukwu F Sylvester-Ikondu
September 2002, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology,
Emmanuel O Idigbe, and Rosemary A Audu, and Olumuyiwa B Salu, and Joseph I Onyewuche, and Chinedum T Oparaugo, and Adesola Z Musa, and Emily H Meschack, and Ugochukwu F Sylvester-Ikondu
April 2005, Georgian medical news,
Emmanuel O Idigbe, and Rosemary A Audu, and Olumuyiwa B Salu, and Joseph I Onyewuche, and Chinedum T Oparaugo, and Adesola Z Musa, and Emily H Meschack, and Ugochukwu F Sylvester-Ikondu
January 2002, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
Emmanuel O Idigbe, and Rosemary A Audu, and Olumuyiwa B Salu, and Joseph I Onyewuche, and Chinedum T Oparaugo, and Adesola Z Musa, and Emily H Meschack, and Ugochukwu F Sylvester-Ikondu
December 2010, BMC infectious diseases,
Emmanuel O Idigbe, and Rosemary A Audu, and Olumuyiwa B Salu, and Joseph I Onyewuche, and Chinedum T Oparaugo, and Adesola Z Musa, and Emily H Meschack, and Ugochukwu F Sylvester-Ikondu
December 2009, International journal of STD & AIDS,
Emmanuel O Idigbe, and Rosemary A Audu, and Olumuyiwa B Salu, and Joseph I Onyewuche, and Chinedum T Oparaugo, and Adesola Z Musa, and Emily H Meschack, and Ugochukwu F Sylvester-Ikondu
January 2017, Journal of immunoassay & immunochemistry,
Emmanuel O Idigbe, and Rosemary A Audu, and Olumuyiwa B Salu, and Joseph I Onyewuche, and Chinedum T Oparaugo, and Adesola Z Musa, and Emily H Meschack, and Ugochukwu F Sylvester-Ikondu
November 2016, Chinese medical journal,
Emmanuel O Idigbe, and Rosemary A Audu, and Olumuyiwa B Salu, and Joseph I Onyewuche, and Chinedum T Oparaugo, and Adesola Z Musa, and Emily H Meschack, and Ugochukwu F Sylvester-Ikondu
May 2001, Journal of acquired immune deficiency syndromes (1999),
Emmanuel O Idigbe, and Rosemary A Audu, and Olumuyiwa B Salu, and Joseph I Onyewuche, and Chinedum T Oparaugo, and Adesola Z Musa, and Emily H Meschack, and Ugochukwu F Sylvester-Ikondu
June 2013, Journal of the International Association of Providers of AIDS Care,
Emmanuel O Idigbe, and Rosemary A Audu, and Olumuyiwa B Salu, and Joseph I Onyewuche, and Chinedum T Oparaugo, and Adesola Z Musa, and Emily H Meschack, and Ugochukwu F Sylvester-Ikondu
January 2012, AIDS research and treatment,
Copied contents to your clipboard!